FDA-Drug2019-11-13Class II
Dr. Reddy's Ranitidine Tablets, USP 150 mg, 24 count bottles, NDC 55111-404-34 (OTC)
Dr. Reddy's Laboratories, Inc.
Hazard
CGMP Deviations: Presence of NDMA impurity detected in product.
Sold states
Product was distributed to major distributors throughout the United States who may have further distributed the product.
Affected count
N/A
Manufactured in
107 College Rd E, N/A, Princeton, NJ, United States
Products
Dr. Reddy's Ranitidine Tablets, USP 150 mg, 24 count bottles, NDC 55111-404-34 (OTC)
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0182-2020Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief